CLDN18.2-targeting nanobody PET probe

· Peking University Cancer Hospital & Institute

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CLDN18.2-targeting nanobody PET probe, covering 2026-03-04 to 2026-03-04. Get the full timeline:

Most recent: Clinical Trial Update: CLDN18.2 Targeting Nanobody Probe for PET Imaging in Solid Tumors [NA]